Medicare Enrolled

Dr. Irfan Ali, M.D.

Epilepsy Physician · Houston, TX
Low-engagement
6701 FANNIN ST, Houston, TX 77030
8328221770
In practice since 2008 (18 years)
NPI: 1154592921 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ali

Dr. Irfan Ali is an epilepsy physician in Houston, TX, with 18 years in practice.

Between the years covered by Open Payments, Dr. Ali received a total of $9,259 from 23 pharmaceutical and/or device companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in epilepsy physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ali is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $9,259 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$9,259
Total received (2018-2024)
Avg $1,323/year across 7 years
Top 17% in TX for epilepsy physician
23
Companies
138
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,596 (60.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,663 (39.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,043
2023
$974
2022
$380
2021
$361
2020
$213
2019
$2,322
2018
$3,966

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
NEUROPACE, INC.
$3,663
NeuroPace, Inc.
$1,774
Medtronic, Inc.
$1,421
DIXI Medical USA Corp
$852
Medtronic USA, Inc.
$617
Abbott Laboratories
$275
Sunovion Pharmaceuticals Inc.
$222
Nevro Corp.
$74
Neuronetics, Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$55
Nuvectra Corporation
$32
SI-BONE, INC.
$27
Averitas Pharma Inc.
$27
Medtronic Vascular, Inc.
$24
Siemens Medical Solutions USA, Inc.
$21
Collegium Pharmaceutical, Inc.
$18
Allergan, Inc.
$17
GlaxoSmithKline, LLC.
$15
Biohaven Pharmaceuticals, Inc.
$14
Teva Pharmaceuticals USA, Inc.
$14
DePuy Synthes Sales Inc.
$12
Allergan Inc.
$11
Stryker Corporation
$11
Top 3 companies account for 74.1% of total payments
Associated products mentioned in payments ›
AJOVY · APTIOM · Algovita · BOTOX · Cios Select · ClosureFast · ELYXYB - celecoxib · ETERNA · IVS - VERTEBRAL AUGMENTATION PRODUCTS · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · MONOVISC · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · Omnia · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · QUTENZA · RNS System · SCS IPGs · SCS leads · SHINGRIX · VRAYLAR · Vanta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a epilepsy physician in Houston?
Compare epilepsy physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse epilepsy physicians nearby

Geographic Context

Epilepsy Physicians within 10 mi
11
Per 100K population
0.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ali is a epilepsy physician, and high industry engagement (low-engagement, top 17%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ali receive payments from pharmaceutical companies?
Yes. Dr. Ali received a total of $9,259 from 23 companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Ali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Epilepsy Physicians in Houston
Browse epilepsy physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Epilepsy Physicians in TX
Epilepsy Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Epilepsy Physicians in TX
Which TX epilepsy physicians receive the most from drug and device companies.
By company
NEUROPACE, INC. Payments to Doctors
See all physicians who received payments from NEUROPACE, INC..
By company
NeuroPace, Inc. Payments to Doctors
See all physicians who received payments from NeuroPace, Inc..
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →